Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed with Cisplatin and Cetuximab in Recurrent/Metastatic Head and Neck Cancer
NCT01057589Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of pemetrexed in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Eli Lilly and Company. Started Feb 2010; status: completed.
02
Drugs
pemetrexed
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01057589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057589.